Global orthopedic sales totaled $62 billion in 2024, an increase of 5% compared to 2023. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
The Numbers
The company grew in the mid-single-digits amid steadily improving performance, operations and new product uptake.
The company grew in the low-single-digits as its completes a distributor transition but had notable wins in trauma and bone growth therapies.
August 6, 2025
,
Julie A. Vetalice
The company grew in the mid-single-digits amid steadily improving performance, operations and new product uptake.
August 8, 2025
,
The company grew in the low-single-digits as its completes a distributor transition but had notable wins in trauma and bone growth therapies.
August 7, 2025
,
Funds will support development of the company’s novel therapies for periprosthetic joint infection, a complication of joint replacement procedures.
August 6, 2025
,
The company continued its market-leading growth as it seeks to meaningfully reduce the complexity and variability of spine surgery.
August 6, 2025
,
MACI continued its impressive growth with strong business fundamentals, while MACI Arthro is gearing up to be a major growth driver.
August 6, 2025
,
Excluding its divested spinal implant business, Stryker’s orthopedic sales grew double-digits in the second quarter of 2025.
August 4, 2025
,
The company’s orthopedic business remains challenged by supply chain troubles, but BioBrace and foot and ankle have been bright spots.
August 1, 2025
,
A look at sports medicine’s consolidation, news and acquisition activity, funding environment and upcoming innovation.
July 23, 2025
,
Proceeds will primarily support continued commercialization of the company’s implants for total and reverse total shoulder arthroplasty, as well as new product development.
July 21, 2025
,
The company’s orthopedic growth declined for the second consecutive quarter but new products are set to bolster second half performance.
July 18, 2025
,
Carlsmed is a commercial-stage medical technology company offering artificial intelligence-enabled personalized spine surgery solutions.
July 15, 2025
,
The company offers implant systems for shoulder arthroplasty, as well as enabling technologies, instrument systems, support and surgeon-to-surgeon collaboration.
July 15, 2025
,
Our chart of the month tracks Globus Medical’s quarterly pro forma growth since the beginning of 2023, showing its overall solid performance.
July 8, 2025
,
The company has developed a device to remove surgical cement during hip joint revision procedures.
July 7, 2025
,
The company’s aprevo Technology Platform combines proprietary AI-driven software with patient-specific fusion devices to personalize surgical procedures, improve patient outcomes and reduce complications.
